{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:24:34Z","timestamp":1790713474139,"version":"4.1.0"},"reference-count":134,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":391,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jacc.2020.12.072","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:11:23Z","timestamp":1621296683000},"page":"2551-2572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Contemporary and Future Approaches to\u00a0Precision Medicine in Inherited\u00a0Cardiomyopathies"],"prefix":"10.1016","volume":"77","author":[{"given":"Diane","family":"Fatkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Calkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C.","family":"Kovacic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2020.12.072_bib1","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0092-8674(90)90274-I","article-title":"A\u00a0molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation","volume":"62","author":"Geisterfer-Lowrance","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.jacc.2020.12.072_bib2","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/CIR.0000000000000682","article-title":"Cardiomyopathy in children: classification and diagnosis. a scientific statement from the American Heart Association","volume":"140","author":"Lipshultz","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.12.072_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.119.002460","article-title":"Evaluating the clinical validity of hypertrophic cardiomyopathy genes","volume":"12","author":"Ingles","year":"2019","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.jacc.2020.12.072_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41436-018-0036-2","article-title":"A\u00a0gene-centric strategy for identifying disease-causing rare variants in dilated cardiomyopathy","volume":"21","author":"Horvat","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.jacc.2020.12.072_bib5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCRESAHA.110.223834","article-title":"Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history","volume":"108","author":"Seidman","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2020.12.072_bib6","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1161\/01.RES.86.7.737","article-title":"Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy","volume":"86","author":"Tyska","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2020.12.072_bib7","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s12265-009-9129-2","article-title":"Insights into human b-cardiac myosin function from single molecule and single cell studies","volume":"2","author":"Sivaramakrishnan","year":"2009","journal-title":"J\u00a0Cardiovasc Transl Res"},{"key":"10.1016\/j.jacc.2020.12.072_bib8","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.24634","article-title":"Effects of myosin variants on interacting heads motif explain distinct hypertrophic and dilated cardiomyopathy phenotypes","volume":"6","author":"Alamo","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.jacc.2020.12.072_bib9","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.119.042339","article-title":"Myosin sequestration regulates sarcomere function, cardiomyocyte energetics, and metabolism, informing the pathogenesis of hypertrophic cardiomyopathy","volume":"141","author":"Toepfer","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.12.072_bib10","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1172\/JCI11093","article-title":"An abnormal Ca2+ response in mutant sarcomere protein-mediate familial hypertrophic cardiomyopathy","volume":"106","author":"Fatkin","year":"2000","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2020.12.072_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJMra1509267","article-title":"Arrhythmogenic right ventricular cardiomyopathy","volume":"376","author":"Corrado","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.12.072_bib12","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJMoa0808138","article-title":"A\u00a0new diagnostic test for arrhythmogenic right ventricular cardiomyopathy","volume":"360","author":"Asimaki","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.12.072_bib13","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/eurheartj\/ehaa141","article-title":"The role of genetics in cardiovascular disease: arrhythmogenic cardiomyopathy","volume":"41","author":"James","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.12.072_bib14","doi-asserted-by":"crossref","first-page":"a021063","DOI":"10.1101\/cshperspect.a021063","article-title":"Genetics and disease of ventricular muscle","volume":"4","author":"Fatkin","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jacc.2020.12.072_bib15","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/CIRCRESAHA.116.309396","article-title":"Dilated cardiomyopathy: genetic determinants and mechanisms","volume":"121","author":"McNally","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2020.12.072_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cardfail.2018.03.004","article-title":"Genetic evaluation of cardiomyopathy\u2014a Heart\u00a0Failure Society of America practice guideline","volume":"24","author":"Hershberger","year":"2018","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2020.12.072_bib17","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/j.jacc.2011.06.011","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"58","author":"Gersh","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.12.072_bib18","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.12.072_bib19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/CIRCULATIONAHA.114.014283","article-title":"Clinical impact of contemporary cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy","volume":"132","author":"Maron","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.12.072_bib20","first-page":"93","article-title":"Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure","volume":"1","author":"Lavie","year":"2013","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2020.12.072_bib21","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/eurheartj\/ehv090","article-title":"Exercise and the heart: the good, the bad, and the ugly","volume":"36","author":"Sharma","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.12.072_bib22","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.12.072_bib23","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"16","author":"Yancy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.12.072_bib24","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart\u00a0Failure of the European Society of Cardiology (ESC)","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.12.072_bib25","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","article-title":"Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implication for clinical practice: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"37","author":"Pinto","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.12.072_bib26","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJM200004133421502","article-title":"Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy","volume":"342","author":"Felker","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.12.072_bib27","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.amjcard.2011.06.022","article-title":"Review and meta-analysis of the frequency of familial dilated cardiomyopathy","volume":"108","author":"Petretta","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2020.12.072_bib28","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/eurheartj\/ehq025","article-title":"Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"31","author":"Marcus","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.12.072_bib29","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2020.12.072_bib30","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJM199912023412302","article-title":"Missense mutations in the rod domain of the lamin A\/C gene as causes of dilated cardiomyopathy and conduction-system disease","volume":"341","author":"Fatkin","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.12.072_bib31","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/CIRCULATIONAHA.119.044366","article-title":"Hypertrophic cardiomyopathy with left ventricular systolic dysfunction: Insights from the SHaRe registry","volume":"141","author":"Marstrand","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.12.072_bib32","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.hlc.2019.11.018","article-title":"Familial dilated cardiomyopathy","volume":"29","author":"Peters","year":"2020","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.jacc.2020.12.072_bib33","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jacc.2020.06.011","article-title":"Penetrance of hypertrophic cardiomyopathy in sarcomere protein mutation carriers","volume":"76","author":"Lorenzini","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.12.072_bib34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.jacc.2020.12.072_bib35","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/eurheartj\/ehu301","article-title":"Atlas of the clinical genetics of human dilated cardiomyopathy","volume":"36","author":"Haas","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.12.072_bib36","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ejhg.2013.16","article-title":"Doubly heterozygous LMNA and TTN mutations revealed by exome sequencing in a severe form of dilated cardiomyopathy","volume":"21","author":"Roncarati","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jacc.2020.12.072_bib37","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.jacc.2004.07.045","article-title":"Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy","volume":"44","author":"Van Driest","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.12.072_bib38","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.116.001666","article-title":"Multiple gene variants in hypertrophic cardiomyopathy in the era of next-generation sequencing","volume":"10","author":"Burns","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacc.2020.12.072_bib39","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/CIRCGENETICS.113.000288","article-title":"Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosmal gene-related arrhythmogenic right ventricular cardiomyopathy","volume":"6","author":"Rigato","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacc.2020.12.072_bib40","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/eurheartj\/ehu509","article-title":"Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated mutation carriers","volume":"36","author":"Bhonsale","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.12.072_bib41","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCGENETICS.114.001003","article-title":"Clinical presentation, long-term follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia\/cardiomyopathy patients and family members","volume":"8","author":"Groeneweg","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacc.2020.12.072_bib42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41467-019-13690-5","article-title":"Genome-wide association and Mendelian randomisation analysis provides insights into the pathogenesis of heart failure","volume":"11","author":"Shah","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacc.2020.12.072_bib43","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/s41467-020-15823-7","article-title":"Analysis of cardiac magnetic resonance imaging in 36,000 individuals yields genetic insights into dilated cardiomyopathy","volume":"11","author":"Pirruccello","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacc.2020.12.072_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172995","article-title":"Exome-wide association study reveals novel susceptibility genes to sporadic dilated cardiomyopathy","volume":"12","author":"Esslinger","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2020.12.072_bib45","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1172\/JCI84840","article-title":"Large-scale genome-wide analysis identifies genetic variants association with cardiac structure and function","volume":"127","author":"Wild","year":"2017","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2020.12.072_bib46","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.119.002804","article-title":"Meta-analysis of 26638 individuals identifies two genetic loci associated with left ventricular ejection fraction","volume":"13","author":"Choquet","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.jacc.2020.12.072_bib47","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/CIRCULATIONAHA.118.035774","article-title":"Phenotypic refinement of heart failure in a national biobank facilitates genetic discovery","volume":"139","author":"Aragam","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.12.072_bib48","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/eurheartj\/ehr105","article-title":"A\u00a0genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy","volume":"32","author":"Villard","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.12.072_bib49","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1161\/CIRCULATIONAHA.119.041161","article-title":"Genome-wide analysis of left ventricular image-derived phenotypes identified fourteen loci associated with cardiac morphogenesis and heart failure development","volume":"140","author":"Aung","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.12.072_bib50","first-page":"11","article-title":"A\u00a0genome-wide association study of idiopathic dilated cardiomyopathy in African Americans","volume":"8","author":"Xu","year":"2018","journal-title":"J\u00a0Pers Med"},{"key":"10.1016\/j.jacc.2020.12.072_bib51","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41588-018-0047-6","article-title":"Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases","volume":"50","author":"Kanai","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2020.12.072_bib52","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.117.002151","article-title":"Variants in NKX2-5 and FLNC cause dilated cardiomyopathy and sudden cardiac death","volume":"11","author":"Sveinbjornsson","year":"2018","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.jacc.2020.12.072_bib53","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/eurheartj\/eht251","article-title":"A\u00a0genome-wide association study identifies 6p21 as a novel risk locus for dilated cardiomyopathy","volume":"35","author":"Meder","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.12.072_bib54","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1056\/NEJMoa1605086","article-title":"Genetic risk, adherence to a healthy lifestyle, and coronary artery disease","volume":"375","author":"Khera","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.12.072_bib55","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.jacc.2018.07.079","article-title":"Genomic risk prediction of coronary artery disease in 480,000 adults: implications for primary prevention","volume":"72","author":"Inouye","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.12.072_bib56","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1161\/CIRCULATIONAHA.116.024143","article-title":"Genetic risk prediction of atrial fibrillation","volume":"135","author":"Lubitz","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.12.072_bib57","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1161\/CIRCULATIONAHA.117.031431","article-title":"Genetic predisposition, clinical risk factor burden, and lifetime risk of atrial fibrillation","volume":"137","author":"Weng","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.12.072_bib58","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamacardio.2019.4268","article-title":"Association of obesity with adverse long-term outcome in hypertrophic cardiomyopathy","volume":"5","author":"Fumagalli","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2020.12.072_bib59","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ijcard.2006.07.174","article-title":"Epidemiology of fat replacement of the right ventricular myocardium determined by multislice computed tomography using a logistic regression model","volume":"119","author":"Imada","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2020.12.072_bib60","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2018.03.462","article-title":"Genetic etiology for alcohol-induced cardiac toxicity","volume":"71","author":"Ware","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.12.072_bib61","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cardfail.2017.03.003","article-title":"Truncating titin (TTN) variants in chemotherapy-induced cardiomyopathy","volume":"23","author":"Linschoten","year":"2017","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2020.12.072_bib62","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCULATIONAHA.118.037934","article-title":"Genetic variants associated with cancer therapy-induced cardiomyopathy","volume":"140","author":"Garcia-Pavia","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.12.072_bib63","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12012-014-9252-4","article-title":"Alcoholic cardiomyopathy: pathophysiologic insights","volume":"14","author":"Piano","year":"2014","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.jacc.2020.12.072_bib64","first-page":"78","article-title":"Natural history and prognostic factors in alcoholic cardiomyopathy","volume":"3","author":"Guzzo-Merello","year":"2015","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2020.12.072_bib65","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/heartjnl-2017-312103","article-title":"Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention","volume":"104","author":"Henriksen","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2020.12.072_bib66","doi-asserted-by":"crossref","first-page":"270ra6","DOI":"10.1126\/scitranslmed.3010134","article-title":"Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease","volume":"7","author":"Roberts","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jacc.2020.12.072_bib67","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/eurheartj\/ehi325","volume":"26","author":"Pelliccia","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.12.072_bib68","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.jacc.2015.09.035","volume":"66","author":"Maron","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.12.072_bib69","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jacc.2018.06.054","article-title":"Exercise training for patients with hypertrophic cardiomyopathy: JACC Review Topic of the Week","volume":"72","author":"Dias","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.12.072_bib70","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/2047487313501277","article-title":"Efficacy of exercise training in symptomatic patients with hypertrophic cardiomyopathy: results of a structured exercise training program in a cardiac rehabilitation centre","volume":"22","author":"Klempfner","year":"2015","journal-title":"Eur J Prevent Cardiol"},{"key":"10.1016\/j.jacc.2020.12.072_bib71","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.2017.2503","article-title":"Effect of moderate-intensity exercise training on peak oxygen consumption in patients with hypertrophic cardiomyopathy: a randomized clinical trial","volume":"317","author":"Saberi","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2020.12.072_bib72","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jacc.2013.06.033","article-title":"Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated desmosomal mutation carriers","volume":"62","author":"James","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.12.072_bib73","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/ejhf.181","article-title":"Vigorous exercise activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members","volume":"16","author":"Saberniak","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2020.12.072_bib74","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1093\/eurheartj\/ehv110","article-title":"Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy","volume":"36","author":"Ruwald","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.12.072_bib75","article-title":"Exercise has a disproportionate role in the pathogenesis of arrhythmogenic right ventricular dysplasia\/cardiomyopathy in patients without desmosomal mutations","volume":"3","author":"Sawant","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2020.12.072_bib76","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1001\/jamacardio.2019.4638","article-title":"Association of race with disease expression and clinical outcomes among patients with hypertrophic cardiomyopathy","volume":"5","author":"Eberly","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2020.12.072_bib77","first-page":"2110","article-title":"A\u00a0novel risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)","volume":"35","author":"O\u2019Mahony","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.12.072_bib78","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1161\/CIRCULATIONAHA.108.816884","article-title":"Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population","volume":"120","author":"Levy","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.12.072_bib79","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehz103","article-title":"A\u00a0new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy","volume":"40","author":"Cadrin-Tourigny","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.12.072_bib80","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.jacc.2012.05.050","article-title":"R222Q SCN5A mutation is associated with reversible ventricular ectopy and dilated cardiomyopathy","volume":"60","author":"Mann","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.12.072_bib81","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1752-8062.2008.00017.x","article-title":"Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LDB3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy","volume":"1","author":"Hershberger","year":"2008","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jacc.2020.12.072_bib82","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.jacc.2010.09.084","article-title":"SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism","volume":"57","author":"McNair","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.12.072_bib83","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.hrthm.2012.06.029","article-title":"Escape capture bigeminy: phenotypic marker of cardiac sodium channel voltage sensor mutation R222Q","volume":"9","author":"Nair","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2020.12.072_bib84","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jacc.2012.02.052","article-title":"Multifocal ectopic Purkinje-related premature contractions: a new SCN5A-related cardiac channelopathy","volume":"60","author":"Laurent","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.12.072_bib85","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12881-018-0599-4","article-title":"Rapid and effective response of the R222Q SCN5A to quinidine treatment in a patient with Purkinje-related ventricular arrhythmia and familial dilated cardiomyopathy: a case report","volume":"19","author":"Zakrzewska-Koperska","year":"2018","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.jacc.2020.12.072_bib86","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/j.jacc.2019.10.011","article-title":"Precision medicine in the management of dilated cardiomyopathy: JACC state-of-the-art review","volume":"74","author":"Fatkin","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.12.072_bib87","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1161\/CIRCULATIONAHA.110.970673","article-title":"Hum Mol Genet 2009;18:241\u20137. Mitogen-activated protein kinase inhibitors improve heart function and prevent fibrosis in cardiomyopathy caused by mutation in lamin A\/C gene","volume":"123","author":"Wu","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.12.072_bib88","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1093\/hmg\/dds265","article-title":"Abnormal p38a mitogen-activated protein kinase signaling in dilated cardiomyopathy caused by lamin A\/C gene mutation","volume":"21","author":"Muchir","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jacc.2020.12.072_bib89","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1126\/science.aad3456","article-title":"A\u00a0small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice","volume":"351","author":"Green","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jacc.2020.12.072_bib90","doi-asserted-by":"crossref","first-page":"E8143","DOI":"10.1073\/pnas.1809540115","article-title":"Deciphering the super relaxed state of human b-cardiac myosin and the mode of action of mavacamten from myosin molecules to muscle fibers","volume":"115","author":"Anderson","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2020.12.072_bib91","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1126\/science.1200113","article-title":"Cardiac myosin activation: a potential therapeutic approach for systolic heart failure","volume":"331","author":"Malik","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jacc.2020.12.072_bib92","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2020.12.072_bib93","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/j.jacc.2020.03.064","article-title":"Evaluation of mavacamten in symptomatic patients with nonobstructive hypertrophic cardiomyopathy","volume":"75","author":"Ho","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.12.072_bib94","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1161\/CIRCULATIONAHA.117.030792","article-title":"Risk stratification in arrhythmogenic right ventricular cardiomyopathy","volume":"136","author":"Calkins","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.12.072_bib95","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.12.072_bib96","first-page":"28","article-title":"Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis","volume":"5","author":"Di Marco","year":"2017","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2020.12.072_bib97","first-page":"30","article-title":"Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals","volume":"107","author":"Sedaghat-Hamedani","year":"2018","journal-title":"Clin Res Cardol"},{"key":"10.1016\/j.jacc.2020.12.072_bib98","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.jacc.2019.08.1057","article-title":"Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM Registry","volume":"74","author":"Neubauer","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.12.072_bib99","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.hlc.2018.09.010","article-title":"Arrhythmogenic genotypes in familial dilated cardiomyopathy: implications for genetic testing and clinical management","volume":"28","author":"Peters","year":"2019","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.jacc.2020.12.072_bib100","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2016.08.058","article-title":"Long-term arrhythmic and nonarrhythmic outcomes of lamin A\/C mutation carriers","volume":"68","author":"Kumar","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.12.072_bib101","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","article-title":"Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies","volume":"68","author":"Ortiz-Genga","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.12.072_bib102","first-page":"504","article-title":"Filamin C truncation mutations are associated with arrhythmogenic dilated cardiomyopathy and changes in the cell-cell adhesion structures","volume":"4","author":"Begay","year":"2018","journal-title":"J\u00a0Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2020.12.072_bib103","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005371","article-title":"Regional variation in RBM20 causes a highly penetrant arrhythmogenic cardiomyopathy","volume":"12","author":"Parikh","year":"2019","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2020.12.072_bib104","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCGENETICS.113.000374","article-title":"Outcome in phospholamban R14del carriers: results of a large multicentre cohort study","volume":"7","author":"van Rijsingen","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacc.2020.12.072_bib105","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1161\/CIRCULATIONAHA.119.044934","article-title":"Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy","volume":"141","author":"Smith","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.12.072_bib106","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.hrthm.2009.07.041","article-title":"Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES gene","volume":"6","author":"Van Tintelen","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2020.12.072_bib107","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ajhg.2008.01.010","article-title":"Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene","volume":"82","author":"Merner","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jacc.2020.12.072_bib108","first-page":"326","article-title":"Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study","volume":"21","author":"Augusto","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2020.12.072_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169007","article-title":"Titin truncating variants in dilated cardiomyopathy: prevalence and genotype-phenotype correlations","volume":"12","author":"Franaszczyk","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2020.12.072_bib110","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006832","article-title":"Clinical phenotype and prognosis of dilated cardiomyopathy caused by truncating variants in the TTN gene","volume":"13","author":"Akhtar","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2020.12.072_bib111","doi-asserted-by":"crossref","first-page":"108","DOI":"10.7326\/0003-4819-143-2-200507190-00009","article-title":"Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease","volume":"143","author":"Mahon","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2020.12.072_bib112","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1161\/CIRCGENETICS.110.958918","article-title":"Evaluation of left ventricular enlargement as a marker of early disease in familial dilated cardiomyopathy","volume":"4","author":"Fatkin","year":"2011","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacc.2020.12.072_bib113","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/CIRCGENETICS.109.862128","article-title":"Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy","volume":"2","author":"Ho","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacc.2020.12.072_bib114","first-page":"291","article-title":"Global and regional echocardiographic strain to assess the early phase of hypertrophic cardiomyopathy due to sarcomeric mutations","volume":"21","author":"Baudry","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2020.12.072_bib115","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCGENETICS.112.962761","article-title":"Subtle abnormalities in contractile function are an early manifestation of sarcomere mutations in dilated cardiomyopathy","volume":"5","author":"Lakdawala","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacc.2020.12.072_bib116","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00059-016-4498-1","article-title":"Screening first-degree relatives of patients with dilated cardiomyopathy","volume":"42","author":"Sefa Okten","year":"2017","journal-title":"Herz"},{"key":"10.1016\/j.jacc.2020.12.072_bib117","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/ehjci\/jey169","article-title":"Left ventricular 2D speckle tracking echocardiography for detection of systolic dysfunction in genetic, dilated cardiomyopathies","volume":"20","author":"Van der Bijl","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2020.12.072_bib118","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jcmg.2019.02.032","article-title":"Value of speckle tracking-based deformation analysis in screening relatives of patients with asymptomatic dilated cardiomyopathy","volume":"13","author":"Verdonschot","year":"2020","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2020.12.072_bib119","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijcard.2020.09.036","article-title":"High prevalence of subtle systolic and diastolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients","volume":"324","author":"Paldino","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2020.12.072_bib120","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jcmg.2018.01.012","article-title":"The prognostic value of right ventricular deformation imaging in early arrhythmogenic right ventricular cardiomyopathy","volume":"12","author":"Mast","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2020.12.072_bib121","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1148\/radiol.2018180339","article-title":"Left ventricular strain is abnormal in preclinical and overt hypertrophic cardiomyopathy: cardiac MR feature tracking","volume":"290","author":"Vigneault","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.jacc.2020.12.072_bib122","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1532-429X-13-30","article-title":"Late gadolinium enhanced cardiovascular magnetic resonance of lamin A\/C related dilated cardiomyopathy","volume":"13","author":"Holmstrom","year":"2011","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.jacc.2020.12.072_bib123","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jcmg.2012.06.013","article-title":"CMR-verified interstitial myocardial fibrosis as a marker of subclinical cardiac involvement in LMNA mutation carriers","volume":"5","author":"Fontana","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2020.12.072_bib124","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jcmg.2012.08.019","article-title":"Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy","volume":"6","author":"Puntmann","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2020.12.072_bib125","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12968-017-0380-4","article-title":"Feature tracking CMR reveals abnormal strain in preclinical arrhythmogenic right ventricular dysplasia\/cardiomyopathy: a multisoftware feasibility and clinical implementation study","volume":"19","author":"Bourfiss","year":"2017","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.jacc.2020.12.072_bib126","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2017-000615","article-title":"Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy","volume":"4","author":"Ho","year":"2017","journal-title":"Open Heart"},{"key":"10.1016\/j.jacc.2020.12.072_bib127","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00246-017-1593-x","article-title":"Serum biomarkers of myocardial remodeling and coronary dysfunction in early stages of hypertrophic cardiomyopathy in the young","volume":"38","author":"Fernlund","year":"2017","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jacc.2020.12.072_bib128","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00109-018-1666-1","article-title":"Plasma microRNAs as biomarkers for lamin A\/C-related dilated cardiomyopathy","volume":"96","author":"Toro","year":"2018","journal-title":"J\u00a0Mol Med"},{"key":"10.1016\/j.jacc.2020.12.072_bib129","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180934","article-title":"Differential expression of circulating miRNAs as a novel tool to assess BAG3-associated familial dilated cardiomyopathy","volume":"39","author":"Zaragoza","year":"2019","journal-title":"Biosci Rep"},{"key":"10.1016\/j.jacc.2020.12.072_bib130","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/hrt.77.1.62","article-title":"Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression","volume":"77","author":"Caforio","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2020.12.072_bib131","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1093\/eurheartj\/ehy567","article-title":"An autoantibody identified arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis","volume":"39","author":"Chatterjee","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.12.072_bib132","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/europace\/euaa105","article-title":"Exercise restriction is protective for genotype-positive family members of arrhythmogenic right ventricular cardiomyopathy patients","volume":"22","author":"Wang","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2020.12.072_bib133","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/eurheartj\/ehy730","article-title":"Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventative Cardiology","volume":"40","author":"Pelliccia","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.12.072_bib134","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/CIRCRESAHA.117.310965","article-title":"Opportunities and challenges in cardiovascular pharmacogenomics: from discovery to implementation","volume":"122","author":"Roden","year":"2018","journal-title":"Circ Res"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109721010111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109721010111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:43:21Z","timestamp":1760017401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109721010111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":134,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0735109721010111"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2020.12.072","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contemporary and Future Approaches to\u00a0Precision Medicine in Inherited\u00a0Cardiomyopathies","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2020.12.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}